Its meant to induce weight loss, along with diet and exercise modifications
Peptide Therapy & FDA Regulatory Status 2026 The peptide therapy landscape is changing rapidly, and we believe our patients deserve a straight, accurate explanation of where each therapy stands today
The inverse is equally true
[7] [10] The FDA prescribing information includes a boxed warning regarding the potential risk of thyroid C-cell tumors (observed in rodent studies, though human relevance remains uncertain) and a contraindication for patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2
Eligibility typically depends on medical necessity, FDA-approved use, and meeting criteria like BMI thresholds and documented health conditions
United Healthcare, for instance, often covers it with prior authorization for qualifying individuals